Universität zu Köln

Meissner, Anna-Katharina, Dreher, Lena, Juenger, Stephanie Theresa, Visser-Vandewalle, Veerle ORCID: 0000-0002-5274-7929, Ruge, Maximilian I. and Ruess, Daniel (2022). Frame-based stereotactic implantation of cystoventricular shunts for treating acquired intracerebral cysts. J. Neurosurg., 137 (1). S. 227 - 235. ROLLING MEADOWS: AMER ASSOC NEUROLOGICAL SURGEONS. ISSN 1933-0693

Full text not available from this repository.

Abstract

OBJECTIVE The treatment of symptomatic, progressive or recurrent acquired intracerebral cysts is challenging, especially when they are localized in eloquent structures. In addition to resection, endoscopic fenestration, or stereotactic puncture, the implantation of a cystoventricular shunt by stereotactic guidance (SCVS) has been reported as a minimally invasive procedure; however, only scarce data are available regarding its feasibility and efficacy. Here, the authors evaluated the feasibility and efficacy of frame-based SCVS in patients with acquired intracranial cysts. METHODS In this single-center retrospective analysis, the authors included all patients with acquired intracerebral cysts treated by SCVS following a standardized prospective protocol between 2012 and 2020. They analyzed clinical symptoms, complications, and radiological outcome with regard to cyst volume reduction by 3D volumetry. RESULTS Thirty-four patients (17 females and 17 males; median age 44 years, range 5-77 years) were identified. The median initial cyst volume was 11.5 cm3 (range 1.6-71.6 cm3), and the mean follow-up was 20 months (range 1-82 months). At the last follow-up, 27 of 34 patients (79%) showed a cyst volume reduction of more than 50%. Initial symptoms improved or resolved in 74% (n = 25) and remained stable in 24% (n = 8). No permanent clinical deterioration after treatment was observed. The total complication rate was 5.9%, comprising transient neurological deterioration (n = 1) and ventriculitis (n = 1). There were no deaths. The overall recurrence rate was 11.8%. CONCLUSIONS In this study, SCVS proved to be a safe, minimally invasive, and effective treatment with reliable longterm volume reduction, resulting in clinical improvement and a minor complication rate.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Meissner, Anna-Katharina UNSPECIFIED UNSPECIFIED UNSPECIFIED Dreher, Lena UNSPECIFIED UNSPECIFIED UNSPECIFIED Juenger, Stephanie Theresa UNSPECIFIED UNSPECIFIED UNSPECIFIED Visser-Vandewalle, Veerle UNSPECIFIED orcid.org/0000-0002-5274-7929 UNSPECIFIED Ruge, Maximilian I. UNSPECIFIED UNSPECIFIED UNSPECIFIED Ruess, Daniel UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-676251
DOI:	10.3171/2021.7.JNS211180
Journal or Publication Title:	J. Neurosurg.
Volume:	137
Number:	1
Page Range:	S. 227 - 235
Date:	2022
Publisher:	AMER ASSOC NEUROLOGICAL SURGEONS
Place of Publication:	ROLLING MEADOWS
ISSN:	1933-0693
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language INTRACRANIAL ARACHNOID CYSTS; I-125 BRACHYTHERAPY; RADIOSURGERY; CHILDREN; GLIOMAS; MANAGEMENT Multiple languages Clinical Neurology; Surgery Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/67625